These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29676327)

  • 41. Resolution of papilledema associated with cyclosporine use after change to tacrolimus.
    Yu CW; Kwok JM; Micieli JA
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31748372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Bloody Mess!
    Brodsky MC; Biousse V
    Surv Ophthalmol; 2018; 63(2):268-274. PubMed ID: 28527856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
    Koran LM; Bromberg D; Hornfeldt CS; Shepski JC; Wang S; Hollander E
    Compr Psychiatry; 2010; 51(4):373-9. PubMed ID: 20579510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Papilledema as a sign of intracranial hypertension].
    Serova NK; Eliseeva NM
    Vestn Oftalmol; 2022; 138(4):87-93. PubMed ID: 36004596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effective treatment of severe repetitive behaviour with fluvoxamine in a 20 year old autistic female.
    Harvey RJ; Cooray SE
    Int Clin Psychopharmacol; 1995 Sep; 10(3):201-3. PubMed ID: 8675975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased intracranial pressure in spontaneous CSF leak patients is not associated with papilledema.
    Aaron G; Doyle J; Vaphiades MS; Riley KO; Woodworth BA
    Otolaryngol Head Neck Surg; 2014 Dec; 151(6):1061-6. PubMed ID: 25248848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A weed by any other name.
    Burger BM; Chavis PS; Purvin V
    Surv Ophthalmol; 2013; 58(2):176-83. PubMed ID: 22818826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases.
    Nguyen C; Borruat FX
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):275-8. PubMed ID: 15786000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presumed idiopathic intracranial hypertension: A case report and literature review.
    Fiebai B; Chukwuka IO
    Niger J Med; 2011; 20(2):289-91. PubMed ID: 21970247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seizures induced by combined levomepromazine-fluvoxamine treatment.
    Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A
    Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prazosin addition to fluvoxamine: A preclinical study and open clinical trial in OCD.
    Feenstra MGP; Klompmakers A; Figee M; Fluitman S; Vulink N; Westenberg HGM; Denys D
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):310-319. PubMed ID: 26712326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bilateral papilledema: prospective study of fifty patients].
    Deschamps R; Dehais C; Heran F; Obadia M; Laloum L; Fechner C; Vignal-Clermont C; Gout O
    Rev Neurol (Paris); 2008 Jan; 164(1):42-6. PubMed ID: 18342056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of intracranial hypertension and papilledema associated with nephropathic cystinosis and ocular involvement.
    Parnes A; Wassner SJ; Weinstein JM
    Binocul Vis Strabismus Q; 2008; 23(1):37-40. PubMed ID: 18393938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA; Bullock T; Fineberg N
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract]   [Full Text] [Related]  

  • 55. Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.
    Diaferia G; Mundo E; Bianchi Y; Ronchi P
    J Clin Psychopharmacol; 1994 Feb; 14(1):78-9. PubMed ID: 8151009
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluvoxamine for phobia of storms.
    Balon R
    Acta Psychiatr Scand; 1999 Sep; 100(3):244-5; discussion 245-6. PubMed ID: 10493092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased intracranial pressure in patients with cystinosis.
    Rogers DL; McGregor ML
    J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuro-Ophthalmologic Monitoring in the Management of Increased Intracranial Pressure From Leaking Arachnoid Cysts.
    Deveney TK; Lebas M; Lobo RR; Maher CO; Trobe JD
    J Neuroophthalmol; 2021 Dec; 41(4):e535-e540. PubMed ID: 33734153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluvoxamine-Associated Galactorrhea: A Case Report.
    Chakladar A; Singh J; Tak NK; Patra BN; Sagar R
    J Clin Psychopharmacol; 2020; 40(1):101-102. PubMed ID: 31804454
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug induced intracranial hypertension associated with sulphasalazine treatment.
    Sevgi E; Yalcin G; Kansu T; Varli K
    Headache; 2008 Feb; 48(2):296-8. PubMed ID: 18070060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.